Stockreport

Intensity Therapeutics Signs Clinical Collaboration Agreement with Bristol Myers Squibb for Advanced Solid Tumors

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Phase 2 clinical trial to evaluate combination of INT230-6 and Yervoy® (ipilimumab) WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics today announced it has en [Read more]